Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2018